Litera Expands Collaboration Suite With Acquisition of AxxiTRIALS Clinical Trials Portal
Enables Secure Global Document Sharing and Community Management Tools for Life Sciences
(firmenpresse) - MCLEANSVILLE, NC -- (Marketwired) -- 08/15/13 -- Litera® announces the acquisition of AxxiTRIALS, a leading Clinical Trials Portal solution providing life science companies and clinical research organizations (CROs) with a platform designed to dramatically speed site start-up, patient recruitment, and end-to-end clinical trial operations.
"This acquisition is in keeping with Litera's continued strategic focus on secure, compliant collaboration and nicely aligns with our content management product portfolio," said Litera President Karen Massand. "We see AxxiTRIALS, with its emphasis on outstanding user interface, community building and engagement tools, together with Litera's powerful document lifecycle, security and collaboration solutions as an absolutely unbeatable combination."
AxxiTRIALS improves operating efficiencies by uniting global trial teams, from Sponsor, CRO and sites, under a single interface that is easy to use, engaging and integrated with existing systems. AxxiTRIALS' customizable workflow tools and compliant document management system speeds the site start-up process, ensures compliance, centralizes key trial information, creates community and keeps investigators and site coordinators engaged throughout the clinical trial.
"Pharmaceutical, medical device, biotech and clinical research organizations that leverage the power of the web see a tremendous acceleration of their trials, particularly in the areas of start-up and patient recruitment, enabling life-saving products to get to market faster," said Susan MH Lewenz, founder of AxxiTRIALS and now VP and General Manager at Litera for the AxxiTRIALS franchise. "Interestingly, the CRO clients who have private-labeled our offering tell us that it has even helped them win new business, as many trial sponsors have now witnessed this speed improvement and demand a portal be used for their projects."
AxxiTRIALS is used for trials of all sizes in locations all around the world to accelerate document handling from feasibility and site start-up documentation, to ongoing safety alert, training and communications management, through the locking of the trial master file. Like other Litera products, AxxiTRIALS is designed to be so intuitive that it requires little or no training, works on any device anywhere in the world and provides the right content and tools for the business process.
AxxiTRIALS joins a powerful suite offered by Litera, including its Galaxy portal solution for document and matter collaboration across enterprises, as well as solutions for document templates and numbering, content assembly, document comparison, rights management, large/secure file transfer and synchronization, and metadata management.
Litera offers a comprehensive suite of cyber-secure document creation, collaboration, comparison, control and cleaning technology that provides organizations with unsurpassed content confidence; information workers and mobile professionals can manage their documents and data with a degree of control not available through any other applications on the market. Litera's patented solutions enable more secure and effective collaboration between people, teams and organizations to empower ideas that drive success. Visit now.
Litera and Galaxy are registered trademarks of Litera Corp. All other brand names, product names, or trademarks belong to their respective holders.
Contact:
Michael Susong
(336)375-2991 x121
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 15.08.2013 - 13:04 Uhr
Sprache: Deutsch
News-ID 288187
Anzahl Zeichen: 0
contact information:
Town:
MCLEANSVILLE, NC
Kategorie:
Healthcare
Diese Pressemitteilung wurde bisher 208 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Litera Expands Collaboration Suite With Acquisition of AxxiTRIALS Clinical Trials Portal"
steht unter der journalistisch-redaktionellen Verantwortung von
Litera (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
